Genomics and COVID-19 Vaccine Adverse Events

计划入组 6,325 人 · 首次发布于 2022 年 1 月 28 日

Vertebroplasty In The Treatment Of Acute Fracture Trial - The VITTA Trial

计划入组 2 人 · 首次发布于 2015 年 2 月 25 日

Application of Real-time PCR Platform for Detection of Vittaforma Corneae Among Patients With Microsporidia Keratitis

首次发布于 2018 年 6 月 11 日

CB-PURE(Vitti Labs LLC.)

CORD PLASMA(Vitti Labs LLC.)

Umbilical Cord Tissue MSC Exosomes(Vitti Lab)

Vitti Labs, LLC

United States

ASST FATEBENEFRATELLI SACCO

Italy

VITA 34 AG

Germany

Researchers Identify Genetic Mechanism Behind Rare Blood Clotting in Johnson & Johnson and AstraZeneca COVID Vaccines

Immunic's Vidofludimus Calcium Shows Promising MS Data as Phase 3 Trials Approach 2026 Readout

Immunic's Vidofludimus Calcium Shows Promise in Multiple Sclerosis Treatment